Reuters logo
BRIEF-Orient Europharma and Mycenax Biotech sign drug authorization distribution contract
December 28, 2016 / 10:13 AM / a year ago

BRIEF-Orient Europharma and Mycenax Biotech sign drug authorization distribution contract

Dec 28 (Reuters) - Orient Europharma and Mycenax Biotech :

* The two companies signed a drug authorization distribution contract with a term of ten years

* Says Orient Europharma will get right to sell TuNEX product of Mycenax Biotech in nine countries in Southeast Asia

Source text in Chinese: goo.gl/TfgEfu; goo.gl/4Dt4G9

Further company coverage: and (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below